| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Gene Expression Regulation, Neoplastic | 120 | 2026 | 2026 | 7.560 |
Why?
|
| Gene Expression Profiling | 85 | 2025 | 1829 | 5.610 |
Why?
|
| Neoplasms | 37 | 2026 | 2944 | 5.590 |
Why?
|
| Breast Neoplasms | 58 | 2024 | 2603 | 4.180 |
Why?
|
| MicroRNAs | 62 | 2023 | 896 | 4.110 |
Why?
|
| Transcriptome | 38 | 2026 | 1130 | 3.930 |
Why?
|
| Genomic Structural Variation | 6 | 2025 | 95 | 3.680 |
Why?
|
| Biomarkers, Tumor | 39 | 2026 | 1606 | 3.390 |
Why?
|
| Prostatic Neoplasms | 40 | 2025 | 1415 | 3.350 |
Why?
|
| Lung Neoplasms | 48 | 2025 | 1543 | 3.240 |
Why?
|
| Proteomics | 17 | 2026 | 610 | 3.210 |
Why?
|
| Carcinoma, Renal Cell | 15 | 2025 | 222 | 3.040 |
Why?
|
| DNA Methylation | 26 | 2026 | 1092 | 3.020 |
Why?
|
| Genomics | 29 | 2025 | 1619 | 2.940 |
Why?
|
| Kidney Neoplasms | 16 | 2025 | 420 | 2.540 |
Why?
|
| Cell Line, Tumor | 120 | 2026 | 3720 | 2.510 |
Why?
|
| Proteogenomics | 4 | 2025 | 111 | 2.470 |
Why?
|
| Proteome | 10 | 2026 | 290 | 2.390 |
Why?
|
| Brain Neoplasms | 8 | 2025 | 1350 | 2.300 |
Why?
|
| Neoplasm Metastasis | 39 | 2025 | 706 | 2.240 |
Why?
|
| Signal Transduction | 88 | 2025 | 4675 | 2.050 |
Why?
|
| Mass Spectrometry | 8 | 2026 | 362 | 1.900 |
Why?
|
| Genome, Human | 14 | 2021 | 1322 | 1.890 |
Why?
|
| Epithelial-Mesenchymal Transition | 25 | 2025 | 252 | 1.870 |
Why?
|
| Genes, Neoplasm | 5 | 2019 | 80 | 1.850 |
Why?
|
| Phosphatidylinositol 3-Kinases | 18 | 2022 | 342 | 1.770 |
Why?
|
| Germ-Line Mutation | 3 | 2026 | 373 | 1.770 |
Why?
|
| Humans | 306 | 2026 | 130380 | 1.730 |
Why?
|
| Ovarian Neoplasms | 13 | 2020 | 434 | 1.670 |
Why?
|
| Proto-Oncogene Proteins c-akt | 15 | 2022 | 479 | 1.640 |
Why?
|
| Cell Proliferation | 67 | 2026 | 2478 | 1.640 |
Why?
|
| CpG Islands | 8 | 2026 | 343 | 1.610 |
Why?
|
| Mice | 160 | 2025 | 18213 | 1.580 |
Why?
|
| Adenocarcinoma | 24 | 2018 | 987 | 1.450 |
Why?
|
| Prostate | 18 | 2022 | 410 | 1.430 |
Why?
|
| Animals | 189 | 2026 | 33924 | 1.430 |
Why?
|
| Zinc Finger E-box-Binding Homeobox 1 | 14 | 2023 | 24 | 1.390 |
Why?
|
| Mutation | 38 | 2025 | 6131 | 1.360 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 39 | 2018 | 1004 | 1.350 |
Why?
|
| Germ Cells | 3 | 2026 | 200 | 1.270 |
Why?
|
| Urinary Bladder Neoplasms | 6 | 2026 | 488 | 1.250 |
Why?
|
| Neoplasm Proteins | 11 | 2025 | 683 | 1.250 |
Why?
|
| Antineoplastic Agents | 13 | 2025 | 1796 | 1.240 |
Why?
|
| Gene Rearrangement | 3 | 2021 | 326 | 1.230 |
Why?
|
| TOR Serine-Threonine Kinases | 13 | 2022 | 427 | 1.220 |
Why?
|
| DNA Copy Number Variations | 12 | 2022 | 1031 | 1.190 |
Why?
|
| Databases, Genetic | 8 | 2021 | 507 | 1.150 |
Why?
|
| RNA, Messenger | 29 | 2023 | 2567 | 1.150 |
Why?
|
| Tumor Suppressor Protein p53 | 15 | 2022 | 726 | 1.120 |
Why?
|
| Epithelial Cells | 16 | 2022 | 895 | 1.100 |
Why?
|
| Drug Resistance, Neoplasm | 16 | 2021 | 810 | 1.070 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 10 | 2025 | 341 | 1.040 |
Why?
|
| Receptors, Estrogen | 16 | 2018 | 726 | 1.030 |
Why?
|
| Carcinogenesis | 14 | 2024 | 345 | 1.010 |
Why?
|
| Female | 149 | 2026 | 70281 | 1.000 |
Why?
|
| Triple Negative Breast Neoplasms | 8 | 2025 | 282 | 0.970 |
Why?
|
| PTEN Phosphohydrolase | 15 | 2022 | 254 | 0.970 |
Why?
|
| Mammary Glands, Animal | 14 | 2022 | 448 | 0.950 |
Why?
|
| Receptors, Progesterone | 17 | 2021 | 675 | 0.950 |
Why?
|
| Epigenesis, Genetic | 13 | 2026 | 767 | 0.940 |
Why?
|
| Golgi Apparatus | 8 | 2025 | 93 | 0.920 |
Why?
|
| Carcinoma, Squamous Cell | 10 | 2019 | 753 | 0.910 |
Why?
|
| Whole Genome Sequencing | 4 | 2021 | 359 | 0.900 |
Why?
|
| Mice, Nude | 30 | 2025 | 701 | 0.900 |
Why?
|
| Transcription, Genetic | 15 | 2021 | 1391 | 0.890 |
Why?
|
| Xenograft Model Antitumor Assays | 27 | 2025 | 999 | 0.880 |
Why?
|
| Cell Transformation, Neoplastic | 19 | 2024 | 604 | 0.860 |
Why?
|
| Sequence Analysis, RNA | 9 | 2021 | 419 | 0.850 |
Why?
|
| Membrane Proteins | 14 | 2025 | 1605 | 0.840 |
Why?
|
| Estrogen Receptor alpha | 8 | 2018 | 426 | 0.820 |
Why?
|
| Stem Cells | 10 | 2024 | 713 | 0.800 |
Why?
|
| Cell Movement | 24 | 2025 | 871 | 0.790 |
Why?
|
| Neoplasm Recurrence, Local | 7 | 2021 | 1275 | 0.770 |
Why?
|
| Mammary Neoplasms, Animal | 6 | 2022 | 135 | 0.740 |
Why?
|
| Tamoxifen | 9 | 2018 | 349 | 0.740 |
Why?
|
| Transcription Factors | 19 | 2021 | 2457 | 0.730 |
Why?
|
| Precision Medicine | 5 | 2022 | 381 | 0.730 |
Why?
|
| Prognosis | 32 | 2024 | 4894 | 0.730 |
Why?
|
| RNA, Untranslated | 2 | 2021 | 110 | 0.730 |
Why?
|
| Oncogenes | 7 | 2021 | 163 | 0.710 |
Why?
|
| Wnt Signaling Pathway | 11 | 2025 | 207 | 0.710 |
Why?
|
| Stromal Cells | 14 | 2022 | 310 | 0.710 |
Why?
|
| Software | 5 | 2018 | 737 | 0.700 |
Why?
|
| Tumor Cells, Cultured | 18 | 2021 | 985 | 0.690 |
Why?
|
| Cell Cycle Proteins | 8 | 2025 | 714 | 0.690 |
Why?
|
| MAP Kinase Kinase Kinase 2 | 1 | 2021 | 6 | 0.680 |
Why?
|
| Protein-Tyrosine Kinases | 2 | 2025 | 225 | 0.670 |
Why?
|
| Male | 92 | 2026 | 64524 | 0.670 |
Why?
|
| Endometriosis | 7 | 2024 | 160 | 0.660 |
Why?
|
| Disease Progression | 22 | 2026 | 2207 | 0.660 |
Why?
|
| Cell Differentiation | 19 | 2024 | 1929 | 0.640 |
Why?
|
| Sequence Analysis, DNA | 7 | 2020 | 1723 | 0.640 |
Why?
|
| Disease Susceptibility | 1 | 2021 | 279 | 0.640 |
Why?
|
| Computational Biology | 10 | 2021 | 869 | 0.630 |
Why?
|
| Endometrium | 8 | 2023 | 283 | 0.630 |
Why?
|
| Adaptor Proteins, Signal Transducing | 9 | 2025 | 622 | 0.630 |
Why?
|
| Receptors, Androgen | 9 | 2023 | 415 | 0.630 |
Why?
|
| COUP Transcription Factor II | 6 | 2021 | 99 | 0.610 |
Why?
|
| Protein Array Analysis | 5 | 2018 | 104 | 0.610 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2021 | 253 | 0.600 |
Why?
|
| Ribonuclease III | 9 | 2020 | 100 | 0.590 |
Why?
|
| Glioma | 6 | 2021 | 523 | 0.590 |
Why?
|
| Cystadenocarcinoma, Serous | 4 | 2020 | 50 | 0.590 |
Why?
|
| Proto-Oncogene Proteins c-myc | 6 | 2024 | 188 | 0.590 |
Why?
|
| Estradiol | 10 | 2020 | 470 | 0.590 |
Why?
|
| Pancreatic Neoplasms | 6 | 2026 | 742 | 0.570 |
Why?
|
| Uterus | 8 | 2023 | 539 | 0.570 |
Why?
|
| Transforming Growth Factor beta | 11 | 2021 | 454 | 0.570 |
Why?
|
| Molecular Targeted Therapy | 7 | 2018 | 379 | 0.570 |
Why?
|
| ErbB Receptors | 10 | 2025 | 295 | 0.560 |
Why?
|
| Mice, SCID | 20 | 2022 | 589 | 0.550 |
Why?
|
| Disease Models, Animal | 28 | 2023 | 4664 | 0.550 |
Why?
|
| Protein Kinases | 4 | 2023 | 319 | 0.550 |
Why?
|
| Genes, Tumor Suppressor | 10 | 2020 | 202 | 0.550 |
Why?
|
| Embryo Implantation | 6 | 2021 | 214 | 0.540 |
Why?
|
| Progesterone | 9 | 2020 | 441 | 0.540 |
Why?
|
| Pathology, Molecular | 1 | 2018 | 63 | 0.540 |
Why?
|
| Apoptosis | 25 | 2023 | 1843 | 0.530 |
Why?
|
| Colonic Neoplasms | 3 | 2023 | 262 | 0.520 |
Why?
|
| Liposarcoma | 5 | 2017 | 24 | 0.520 |
Why?
|
| Uterine Neoplasms | 5 | 2019 | 101 | 0.520 |
Why?
|
| RNA, Neoplasm | 8 | 2021 | 127 | 0.500 |
Why?
|
| DEAD-box RNA Helicases | 8 | 2020 | 159 | 0.500 |
Why?
|
| Receptors, Notch | 7 | 2025 | 201 | 0.490 |
Why?
|
| Insulin-Like Growth Factor I | 5 | 2011 | 323 | 0.480 |
Why?
|
| Genetic Predisposition to Disease | 10 | 2026 | 3425 | 0.480 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 22 | 2020 | 1215 | 0.480 |
Why?
|
| Receptors, G-Protein-Coupled | 6 | 2024 | 296 | 0.480 |
Why?
|
| RNA Helicases | 3 | 2022 | 75 | 0.480 |
Why?
|
| Mice, Transgenic | 20 | 2023 | 2346 | 0.460 |
Why?
|
| Neoplastic Stem Cells | 7 | 2021 | 334 | 0.450 |
Why?
|
| Mitochondria | 4 | 2025 | 764 | 0.440 |
Why?
|
| Adenocarcinoma, Clear Cell | 3 | 2023 | 25 | 0.440 |
Why?
|
| Wnt Proteins | 4 | 2021 | 193 | 0.430 |
Why?
|
| Neoplasms, Experimental | 4 | 2019 | 201 | 0.430 |
Why?
|
| Down-Regulation | 16 | 2017 | 655 | 0.430 |
Why?
|
| Antineoplastic Agents, Hormonal | 5 | 2018 | 250 | 0.430 |
Why?
|
| Proteins | 3 | 2015 | 1015 | 0.430 |
Why?
|
| Cell Lineage | 6 | 2020 | 346 | 0.430 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 3 | 2024 | 116 | 0.430 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 10 | 2023 | 174 | 0.420 |
Why?
|
| Receptor Tyrosine Kinase-like Orphan Receptors | 3 | 2022 | 36 | 0.420 |
Why?
|
| Cell Transdifferentiation | 2 | 2016 | 58 | 0.420 |
Why?
|
| DNA Mutational Analysis | 7 | 2015 | 789 | 0.420 |
Why?
|
| Homeodomain Proteins | 7 | 2017 | 568 | 0.420 |
Why?
|
| Colorectal Neoplasms | 5 | 2025 | 622 | 0.420 |
Why?
|
| Mitogen-Activated Protein Kinases | 4 | 2022 | 185 | 0.410 |
Why?
|
| STAT3 Transcription Factor | 6 | 2024 | 231 | 0.410 |
Why?
|
| Immunity | 3 | 2021 | 179 | 0.410 |
Why?
|
| Hormones | 2 | 2020 | 163 | 0.400 |
Why?
|
| Metabolic Networks and Pathways | 4 | 2019 | 194 | 0.400 |
Why?
|
| Forkhead Transcription Factors | 5 | 2022 | 372 | 0.390 |
Why?
|
| Gene Expression Regulation | 15 | 2022 | 2356 | 0.390 |
Why?
|
| Gene Knockdown Techniques | 15 | 2025 | 382 | 0.390 |
Why?
|
| Genes, p53 | 5 | 2020 | 208 | 0.390 |
Why?
|
| Von Hippel-Lindau Tumor Suppressor Protein | 3 | 2017 | 34 | 0.390 |
Why?
|
| Mice, Knockout | 23 | 2021 | 3816 | 0.390 |
Why?
|
| Neoplasm Invasiveness | 13 | 2021 | 628 | 0.390 |
Why?
|
| Proto-Oncogene Proteins | 6 | 2025 | 599 | 0.390 |
Why?
|
| Carcinoma | 3 | 2013 | 284 | 0.390 |
Why?
|
| Tumor Microenvironment | 11 | 2023 | 699 | 0.380 |
Why?
|
| Carcinoma, Pancreatic Ductal | 2 | 2026 | 188 | 0.380 |
Why?
|
| Immunohistochemistry | 15 | 2019 | 1608 | 0.380 |
Why?
|
| Mammary Neoplasms, Experimental | 5 | 2018 | 235 | 0.380 |
Why?
|
| Endometrial Neoplasms | 3 | 2020 | 109 | 0.370 |
Why?
|
| Ovary | 4 | 2015 | 351 | 0.370 |
Why?
|
| Neoplasms, Cystic, Mucinous, and Serous | 1 | 2012 | 9 | 0.370 |
Why?
|
| Neoplasm Staging | 9 | 2021 | 1300 | 0.360 |
Why?
|
| Genetic Heterogeneity | 1 | 2012 | 133 | 0.360 |
Why?
|
| X-linked Nuclear Protein | 2 | 2024 | 14 | 0.360 |
Why?
|
| src-Family Kinases | 3 | 2025 | 92 | 0.350 |
Why?
|
| Base Sequence | 12 | 2018 | 2767 | 0.350 |
Why?
|
| Phosphoproteins | 4 | 2021 | 454 | 0.350 |
Why?
|
| Fatty Acids | 3 | 2026 | 377 | 0.340 |
Why?
|
| Transcription Factor AP-1 | 3 | 2024 | 111 | 0.340 |
Why?
|
| Rectal Neoplasms | 1 | 2012 | 78 | 0.340 |
Why?
|
| Survival Analysis | 9 | 2018 | 1498 | 0.340 |
Why?
|
| Blotting, Western | 14 | 2017 | 1019 | 0.340 |
Why?
|
| Astrocytes | 3 | 2021 | 284 | 0.340 |
Why?
|
| Repressor Proteins | 6 | 2018 | 774 | 0.330 |
Why?
|
| Laryngeal Neoplasms | 3 | 2016 | 85 | 0.330 |
Why?
|
| RNA | 3 | 2024 | 520 | 0.330 |
Why?
|
| Neoplasm Grading | 6 | 2025 | 277 | 0.330 |
Why?
|
| Cells, Cultured | 18 | 2019 | 2905 | 0.320 |
Why?
|
| Kaplan-Meier Estimate | 12 | 2021 | 1076 | 0.320 |
Why?
|
| MAP Kinase Signaling System | 6 | 2024 | 305 | 0.320 |
Why?
|
| Collagen | 3 | 2016 | 277 | 0.320 |
Why?
|
| Neoplasm Transplantation | 12 | 2021 | 360 | 0.320 |
Why?
|
| Chromosomes, Human, Pair 1 | 2 | 2021 | 145 | 0.320 |
Why?
|
| RNA, Small Interfering | 14 | 2018 | 667 | 0.320 |
Why?
|
| Chromosome Aberrations | 4 | 2021 | 575 | 0.310 |
Why?
|
| Nerve Tissue Proteins | 3 | 2023 | 1091 | 0.310 |
Why?
|
| Up-Regulation | 13 | 2021 | 833 | 0.310 |
Why?
|
| RNA Interference | 13 | 2017 | 495 | 0.310 |
Why?
|
| Vesicular Transport Proteins | 2 | 2021 | 140 | 0.310 |
Why?
|
| Gene Expression | 12 | 2020 | 1494 | 0.310 |
Why?
|
| Genitalia, Female | 1 | 2010 | 44 | 0.310 |
Why?
|
| Secretory Vesicles | 3 | 2024 | 20 | 0.300 |
Why?
|
| Androgens | 5 | 2023 | 265 | 0.300 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 1 | 3 | 2017 | 69 | 0.300 |
Why?
|
| Cancer-Associated Fibroblasts | 2 | 2021 | 22 | 0.300 |
Why?
|
| Survival Rate | 11 | 2021 | 2131 | 0.300 |
Why?
|
| Bone Neoplasms | 4 | 2018 | 473 | 0.300 |
Why?
|
| Mesoderm | 1 | 2009 | 105 | 0.300 |
Why?
|
| Nuclear Receptor Coactivator 2 | 3 | 2014 | 147 | 0.290 |
Why?
|
| Heterografts | 10 | 2021 | 193 | 0.290 |
Why?
|
| Middle Aged | 34 | 2026 | 28376 | 0.290 |
Why?
|
| Fibroblasts | 8 | 2016 | 857 | 0.290 |
Why?
|
| Nuclear Proteins | 5 | 2017 | 1229 | 0.290 |
Why?
|
| Extracellular Matrix | 4 | 2016 | 233 | 0.290 |
Why?
|
| Models, Biological | 10 | 2019 | 1390 | 0.290 |
Why?
|
| Telomerase | 4 | 2024 | 153 | 0.290 |
Why?
|
| Prostatic Intraepithelial Neoplasia | 2 | 2022 | 41 | 0.290 |
Why?
|
| Oncogene Proteins | 3 | 2018 | 136 | 0.290 |
Why?
|
| Neoplasm, Residual | 1 | 2009 | 132 | 0.290 |
Why?
|
| Breast | 4 | 2022 | 214 | 0.290 |
Why?
|
| ras Proteins | 4 | 2015 | 147 | 0.290 |
Why?
|
| Transfection | 10 | 2018 | 962 | 0.280 |
Why?
|
| Chromatin | 4 | 2019 | 504 | 0.280 |
Why?
|
| Infertility, Female | 4 | 2021 | 144 | 0.280 |
Why?
|
| Leiomyosarcoma | 3 | 2013 | 23 | 0.280 |
Why?
|
| Cell Line | 7 | 2023 | 2578 | 0.280 |
Why?
|
| Class I Phosphatidylinositol 3-Kinases | 3 | 2020 | 77 | 0.270 |
Why?
|
| Macrophages | 5 | 2022 | 654 | 0.270 |
Why?
|
| Oxidative Phosphorylation | 3 | 2024 | 131 | 0.270 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 2 | 2020 | 72 | 0.270 |
Why?
|
| Cell Cycle | 9 | 2020 | 600 | 0.270 |
Why?
|
| Epigenomics | 3 | 2025 | 183 | 0.260 |
Why?
|
| Gene Dosage | 5 | 2020 | 439 | 0.260 |
Why?
|
| Gene Amplification | 2 | 2021 | 222 | 0.260 |
Why?
|
| Genome | 3 | 2022 | 465 | 0.260 |
Why?
|
| Homeostasis | 4 | 2023 | 716 | 0.260 |
Why?
|
| Databases, Nucleic Acid | 2 | 2008 | 72 | 0.260 |
Why?
|
| Antigens, Ly | 2 | 2020 | 31 | 0.250 |
Why?
|
| DNA-Binding Proteins | 6 | 2017 | 1976 | 0.250 |
Why?
|
| Urologic Neoplasms | 2 | 2017 | 30 | 0.250 |
Why?
|
| Prostatic Neoplasms, Castration-Resistant | 2 | 2021 | 102 | 0.250 |
Why?
|
| Inflammation | 7 | 2024 | 1474 | 0.250 |
Why?
|
| Metabolomics | 5 | 2024 | 504 | 0.250 |
Why?
|
| Carrier Proteins | 3 | 2023 | 1006 | 0.250 |
Why?
|
| Epithelium | 7 | 2023 | 339 | 0.250 |
Why?
|
| Nitriles | 4 | 2021 | 161 | 0.240 |
Why?
|
| beta Catenin | 7 | 2020 | 199 | 0.240 |
Why?
|
| Tumor Suppressor Proteins | 6 | 2022 | 490 | 0.240 |
Why?
|
| Fatty Acid Synthase, Type I | 1 | 2026 | 17 | 0.240 |
Why?
|
| Transforming Growth Factor beta2 | 1 | 2025 | 12 | 0.240 |
Why?
|
| Frizzled Receptors | 1 | 2025 | 20 | 0.240 |
Why?
|
| Receptors, Transforming Growth Factor beta | 2 | 2018 | 106 | 0.240 |
Why?
|
| Adenoma, Oxyphilic | 1 | 2025 | 13 | 0.240 |
Why?
|
| Polymorphism, Single Nucleotide | 6 | 2021 | 2847 | 0.240 |
Why?
|
| Aged | 24 | 2026 | 20888 | 0.240 |
Why?
|
| Aniline Compounds | 1 | 2025 | 20 | 0.230 |
Why?
|
| Kruppel-Like Transcription Factors | 3 | 2015 | 109 | 0.230 |
Why?
|
| Acrylamides | 1 | 2025 | 27 | 0.230 |
Why?
|
| N-Myc Proto-Oncogene Protein | 2 | 2024 | 57 | 0.230 |
Why?
|
| Genetic Testing | 1 | 2012 | 1100 | 0.230 |
Why?
|
| Procollagen-Lysine, 2-Oxoglutarate 5-Dioxygenase | 2 | 2015 | 6 | 0.230 |
Why?
|
| Smoke | 1 | 2026 | 81 | 0.230 |
Why?
|
| Phosphorylation | 8 | 2018 | 1577 | 0.230 |
Why?
|
| DNA Repair | 5 | 2026 | 576 | 0.230 |
Why?
|
| High-Throughput Nucleotide Sequencing | 5 | 2020 | 915 | 0.230 |
Why?
|
| MutS Homolog 2 Protein | 1 | 2025 | 39 | 0.230 |
Why?
|
| Histone-Lysine N-Methyltransferase | 3 | 2020 | 165 | 0.230 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 2 | 2018 | 199 | 0.230 |
Why?
|
| Collagen Type I | 3 | 2022 | 111 | 0.230 |
Why?
|
| Child | 8 | 2025 | 26161 | 0.230 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 12 | 2 | 2018 | 18 | 0.220 |
Why?
|
| Biguanides | 1 | 2025 | 12 | 0.220 |
Why?
|
| Interleukin-8 | 2 | 2016 | 201 | 0.220 |
Why?
|
| Gene Silencing | 5 | 2018 | 230 | 0.220 |
Why?
|
| Interleukin-6 | 3 | 2024 | 412 | 0.220 |
Why?
|
| Mammary Tumor Virus, Mouse | 2 | 2018 | 100 | 0.220 |
Why?
|
| Algorithms | 6 | 2018 | 1679 | 0.220 |
Why?
|
| Mice, Inbred C57BL | 15 | 2024 | 4701 | 0.220 |
Why?
|
| Cell Survival | 9 | 2024 | 837 | 0.220 |
Why?
|
| Proportional Hazards Models | 7 | 2017 | 1399 | 0.220 |
Why?
|
| Cigarette Smoking | 1 | 2026 | 93 | 0.220 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 2 | 2018 | 125 | 0.220 |
Why?
|
| Head and Neck Neoplasms | 3 | 2023 | 633 | 0.220 |
Why?
|
| Plasma Cells | 1 | 2025 | 54 | 0.220 |
Why?
|
| Macrophage Migration-Inhibitory Factors | 1 | 2024 | 13 | 0.220 |
Why?
|
| SOXB1 Transcription Factors | 2 | 2015 | 59 | 0.210 |
Why?
|
| Glutaminase | 1 | 2024 | 18 | 0.210 |
Why?
|
| Phenotype | 9 | 2018 | 4475 | 0.210 |
Why?
|
| Decidua | 6 | 2015 | 139 | 0.210 |
Why?
|
| Intramolecular Oxidoreductases | 1 | 2024 | 40 | 0.210 |
Why?
|
| Gene Fusion | 3 | 2022 | 58 | 0.210 |
Why?
|
| Genes, Essential | 1 | 2024 | 40 | 0.210 |
Why?
|
| SMARCB1 Protein | 2 | 2024 | 42 | 0.210 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 4 | 2017 | 291 | 0.210 |
Why?
|
| Disease-Free Survival | 7 | 2020 | 900 | 0.210 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 4 | 2017 | 583 | 0.210 |
Why?
|
| Cell Adhesion | 6 | 2022 | 307 | 0.210 |
Why?
|
| Mice, Inbred NOD | 7 | 2021 | 301 | 0.210 |
Why?
|
| Promoter Regions, Genetic | 11 | 2017 | 1232 | 0.210 |
Why?
|
| Chromosomes, Human, Pair 3 | 1 | 2024 | 91 | 0.210 |
Why?
|
| Tissue Array Analysis | 8 | 2021 | 135 | 0.210 |
Why?
|
| Morphogenesis | 2 | 2016 | 189 | 0.200 |
Why?
|
| A549 Cells | 2 | 2021 | 49 | 0.200 |
Why?
|
| Carcinoma, Papillary | 2 | 2015 | 92 | 0.200 |
Why?
|
| Actin Cytoskeleton | 2 | 2015 | 50 | 0.200 |
Why?
|
| Intestinal Neoplasms | 1 | 2024 | 36 | 0.200 |
Why?
|
| Aminopyridines | 1 | 2024 | 63 | 0.200 |
Why?
|
| Vascular Endothelial Growth Factor A | 3 | 2014 | 333 | 0.200 |
Why?
|
| Smad4 Protein | 4 | 2018 | 58 | 0.200 |
Why?
|
| Phenylthiohydantoin | 2 | 2021 | 14 | 0.200 |
Why?
|
| Proteasome Endopeptidase Complex | 3 | 2014 | 238 | 0.200 |
Why?
|
| Glutamine | 1 | 2024 | 204 | 0.190 |
Why?
|
| Abortion, Spontaneous | 2 | 2014 | 82 | 0.190 |
Why?
|
| Viral Load | 1 | 2025 | 403 | 0.190 |
Why?
|
| Smad Proteins | 1 | 2023 | 44 | 0.190 |
Why?
|
| Chromosomal Proteins, Non-Histone | 2 | 2016 | 210 | 0.190 |
Why?
|
| Fibroblast Growth Factors | 2 | 2015 | 171 | 0.190 |
Why?
|
| Exome | 5 | 2015 | 1075 | 0.190 |
Why?
|
| Endocytosis | 2 | 2021 | 126 | 0.190 |
Why?
|
| Predictive Value of Tests | 4 | 2018 | 2298 | 0.190 |
Why?
|
| Lung | 4 | 2025 | 1547 | 0.190 |
Why?
|
| Pyrimidines | 5 | 2025 | 452 | 0.190 |
Why?
|
| Benzamides | 2 | 2021 | 125 | 0.190 |
Why?
|
| Nerve Sheath Neoplasms | 2 | 2013 | 20 | 0.190 |
Why?
|
| Information Storage and Retrieval | 1 | 2003 | 64 | 0.190 |
Why?
|
| Pyrroles | 1 | 2024 | 184 | 0.190 |
Why?
|
| Protein Kinase Inhibitors | 3 | 2024 | 614 | 0.190 |
Why?
|
| Mutation Rate | 2 | 2012 | 68 | 0.180 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 4 | 2017 | 1312 | 0.180 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2003 | 134 | 0.180 |
Why?
|
| Antigens, Neoplasm | 1 | 2025 | 398 | 0.180 |
Why?
|
| STAT5 Transcription Factor | 1 | 2022 | 93 | 0.180 |
Why?
|
| Cohort Studies | 6 | 2025 | 5069 | 0.180 |
Why?
|
| Smad2 Protein | 2 | 2019 | 54 | 0.180 |
Why?
|
| Janus Kinase 2 | 2 | 2015 | 138 | 0.180 |
Why?
|
| Early Detection of Cancer | 1 | 2026 | 416 | 0.180 |
Why?
|
| Gene Expression Regulation, Enzymologic | 3 | 2019 | 243 | 0.180 |
Why?
|
| Macrophage Colony-Stimulating Factor | 1 | 2022 | 17 | 0.180 |
Why?
|
| Gene Regulatory Networks | 3 | 2014 | 384 | 0.180 |
Why?
|
| Polymerase Chain Reaction | 5 | 2015 | 1458 | 0.180 |
Why?
|
| Smad3 Protein | 2 | 2019 | 53 | 0.180 |
Why?
|
| Creatine Kinase, BB Form | 1 | 2021 | 5 | 0.180 |
Why?
|
| rho GTP-Binding Proteins | 3 | 2017 | 72 | 0.180 |
Why?
|
| Cell Respiration | 2 | 2019 | 24 | 0.180 |
Why?
|
| Real-Time Polymerase Chain Reaction | 8 | 2017 | 528 | 0.180 |
Why?
|
| Cluster Analysis | 4 | 2013 | 417 | 0.180 |
Why?
|
| raf Kinases | 2 | 2015 | 5 | 0.170 |
Why?
|
| Serine Endopeptidases | 3 | 2017 | 196 | 0.170 |
Why?
|
| Phosphatidylinositol Phosphates | 1 | 2021 | 25 | 0.170 |
Why?
|
| AMP-Activated Protein Kinases | 3 | 2025 | 170 | 0.170 |
Why?
|
| Oncogene Protein v-akt | 2 | 2020 | 33 | 0.170 |
Why?
|
| Genetic Variation | 2 | 2018 | 1556 | 0.170 |
Why?
|
| Endosomes | 1 | 2021 | 72 | 0.170 |
Why?
|
| Mutant Proteins | 2 | 2019 | 111 | 0.170 |
Why?
|
| B7-H1 Antigen | 2 | 2023 | 129 | 0.170 |
Why?
|
| Gene Deletion | 5 | 2017 | 769 | 0.170 |
Why?
|
| Phosphotransferases | 1 | 2021 | 33 | 0.170 |
Why?
|
| Adolescent | 8 | 2025 | 20749 | 0.170 |
Why?
|
| Pediatrics | 2 | 2021 | 1244 | 0.170 |
Why?
|
| Terminology as Topic | 1 | 2003 | 225 | 0.170 |
Why?
|
| Glucosyltransferases | 1 | 2021 | 44 | 0.170 |
Why?
|
| Cadherins | 2 | 2019 | 181 | 0.170 |
Why?
|
| Aurora Kinase A | 3 | 2016 | 36 | 0.170 |
Why?
|
| Adult | 23 | 2025 | 31121 | 0.160 |
Why?
|
| Neuropeptide Y | 1 | 2020 | 34 | 0.160 |
Why?
|
| HEK293 Cells | 6 | 2021 | 811 | 0.160 |
Why?
|
| Spermine Synthase | 1 | 2020 | 2 | 0.160 |
Why?
|
| Spermine | 1 | 2020 | 7 | 0.160 |
Why?
|
| Caveolin 1 | 1 | 2020 | 51 | 0.160 |
Why?
|
| DNA, Neoplasm | 4 | 2020 | 286 | 0.160 |
Why?
|
| Microfilament Proteins | 3 | 2017 | 272 | 0.160 |
Why?
|
| Gene Editing | 1 | 2023 | 227 | 0.160 |
Why?
|
| Bronchi | 1 | 2021 | 98 | 0.160 |
Why?
|
| Bone Morphogenetic Proteins | 1 | 2021 | 126 | 0.160 |
Why?
|
| DNA Replication | 2 | 2020 | 358 | 0.160 |
Why?
|
| Neurons | 3 | 2021 | 2018 | 0.160 |
Why?
|
| Intestines | 1 | 2024 | 589 | 0.160 |
Why?
|
| Carcinoma, Medullary | 1 | 2020 | 17 | 0.160 |
Why?
|
| Sphingolipids | 1 | 2020 | 35 | 0.160 |
Why?
|
| Protein Binding | 8 | 2019 | 1666 | 0.160 |
Why?
|
| Indoles | 2 | 2025 | 199 | 0.160 |
Why?
|
| Enhancer Elements, Genetic | 2 | 2020 | 274 | 0.160 |
Why?
|
| Forkhead Box Protein O1 | 2 | 2017 | 99 | 0.160 |
Why?
|
| Quinazolines | 5 | 2016 | 177 | 0.160 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2020 | 99 | 0.160 |
Why?
|
| Genome, Mitochondrial | 1 | 2020 | 26 | 0.160 |
Why?
|
| Glucose | 1 | 2024 | 853 | 0.160 |
Why?
|
| Mi-2 Nucleosome Remodeling and Deacetylase Complex | 1 | 2019 | 16 | 0.160 |
Why?
|
| Prostatic Hyperplasia | 3 | 2016 | 115 | 0.150 |
Why?
|
| Recurrence | 2 | 2021 | 1481 | 0.150 |
Why?
|
| Cell Growth Processes | 4 | 2014 | 63 | 0.150 |
Why?
|
| Translocation, Genetic | 1 | 2021 | 348 | 0.150 |
Why?
|
| Myocardium | 2 | 2015 | 859 | 0.150 |
Why?
|
| Protein Processing, Post-Translational | 4 | 2016 | 361 | 0.150 |
Why?
|
| Botulinum Toxins, Type A | 2 | 2020 | 126 | 0.150 |
Why?
|
| Obesity | 1 | 2011 | 2380 | 0.150 |
Why?
|
| Osteosarcoma | 2 | 2015 | 275 | 0.150 |
Why?
|
| Peritoneal Neoplasms | 1 | 2020 | 58 | 0.150 |
Why?
|
| Mitogen-Activated Protein Kinase 8 | 1 | 2019 | 20 | 0.150 |
Why?
|
| GTPase-Activating Proteins | 1 | 2019 | 85 | 0.150 |
Why?
|
| Mitogen-Activated Protein Kinase 9 | 1 | 2019 | 15 | 0.150 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 2020 | 152 | 0.150 |
Why?
|
| Case-Control Studies | 8 | 2026 | 3388 | 0.150 |
Why?
|
| Ki-67 Antigen | 2 | 2017 | 105 | 0.150 |
Why?
|
| Wnt-5a Protein | 1 | 2019 | 23 | 0.150 |
Why?
|
| Estrogen Receptor beta | 1 | 2019 | 78 | 0.150 |
Why?
|
| Mice, Inbred BALB C | 7 | 2018 | 974 | 0.150 |
Why?
|
| Cell Culture Techniques | 3 | 2021 | 277 | 0.150 |
Why?
|
| Leiomyoma | 2 | 2017 | 70 | 0.150 |
Why?
|
| Child, Preschool | 2 | 2025 | 14984 | 0.150 |
Why?
|
| Receptor, Notch1 | 2 | 2016 | 77 | 0.150 |
Why?
|
| DNA, Mitochondrial | 3 | 2020 | 232 | 0.150 |
Why?
|
| Nucleic Acid Conformation | 2 | 2010 | 180 | 0.150 |
Why?
|
| Pregnancy | 10 | 2021 | 7381 | 0.150 |
Why?
|
| Esthesioneuroblastoma, Olfactory | 1 | 2018 | 4 | 0.150 |
Why?
|
| Adaptive Immunity | 1 | 2019 | 100 | 0.140 |
Why?
|
| Cell Communication | 3 | 2021 | 188 | 0.140 |
Why?
|
| Extracellular Matrix Proteins | 2 | 2017 | 157 | 0.140 |
Why?
|
| GATA Transcription Factors | 1 | 2018 | 7 | 0.140 |
Why?
|
| Cell Self Renewal | 1 | 2018 | 49 | 0.140 |
Why?
|
| Carcinoma, Hepatocellular | 2 | 2020 | 1005 | 0.140 |
Why?
|
| Inflammatory Breast Neoplasms | 1 | 2018 | 4 | 0.140 |
Why?
|
| Genes, ras | 4 | 2015 | 98 | 0.140 |
Why?
|
| Nose Neoplasms | 1 | 2018 | 32 | 0.140 |
Why?
|
| Cell Polarity | 2 | 2021 | 119 | 0.140 |
Why?
|
| Cathepsins | 1 | 2018 | 24 | 0.140 |
Why?
|
| Drug Screening Assays, Antitumor | 2 | 2020 | 113 | 0.140 |
Why?
|
| Clinical Decision-Making | 2 | 2018 | 312 | 0.140 |
Why?
|
| Cytokines | 4 | 2013 | 1335 | 0.140 |
Why?
|
| Spiro Compounds | 2 | 2015 | 12 | 0.140 |
Why?
|
| Nasal Cavity | 1 | 2018 | 57 | 0.140 |
Why?
|
| Gene Expression Regulation, Developmental | 4 | 2014 | 976 | 0.140 |
Why?
|
| Infertility | 1 | 2019 | 69 | 0.140 |
Why?
|
| Estrogens | 4 | 2021 | 430 | 0.140 |
Why?
|
| Wnt1 Protein | 3 | 2018 | 71 | 0.140 |
Why?
|
| Virus Replication | 1 | 2021 | 597 | 0.140 |
Why?
|
| Proteoglycans | 1 | 2018 | 78 | 0.140 |
Why?
|
| Mutation, Missense | 2 | 2015 | 931 | 0.130 |
Why?
|
| I-kappa B Kinase | 1 | 2017 | 56 | 0.130 |
Why?
|
| Mice, Inbred Strains | 2 | 2015 | 263 | 0.130 |
Why?
|
| Denervation | 1 | 2017 | 23 | 0.130 |
Why?
|
| Transcriptional Activation | 4 | 2020 | 419 | 0.130 |
Why?
|
| Internet | 1 | 2021 | 418 | 0.130 |
Why?
|
| Thy-1 Antigens | 1 | 2017 | 18 | 0.130 |
Why?
|
| Immunomodulation | 1 | 2018 | 81 | 0.130 |
Why?
|
| Sirolimus | 3 | 2014 | 229 | 0.130 |
Why?
|
| Cell Division | 2 | 2013 | 721 | 0.130 |
Why?
|
| Neoplastic Cells, Circulating | 2 | 2015 | 74 | 0.130 |
Why?
|
| Interleukin-17 | 1 | 2018 | 126 | 0.130 |
Why?
|
| NFI Transcription Factors | 1 | 2017 | 51 | 0.130 |
Why?
|
| NF-E2-Related Factor 2 | 2 | 2015 | 130 | 0.130 |
Why?
|
| Dishevelled Proteins | 1 | 2017 | 42 | 0.130 |
Why?
|
| Oncogene Fusion | 1 | 2017 | 26 | 0.130 |
Why?
|
| HMGB Proteins | 1 | 2017 | 8 | 0.130 |
Why?
|
| RGS Proteins | 1 | 2017 | 47 | 0.130 |
Why?
|
| Transplantation, Heterologous | 6 | 2014 | 257 | 0.130 |
Why?
|
| Cell Adhesion Molecules, Neuronal | 1 | 2017 | 82 | 0.130 |
Why?
|
| Enzyme Activation | 3 | 2021 | 582 | 0.130 |
Why?
|
| Liver Neoplasms | 2 | 2020 | 1395 | 0.130 |
Why?
|
| Spinal Cord Regeneration | 1 | 2016 | 4 | 0.130 |
Why?
|
| rho-Associated Kinases | 1 | 2017 | 48 | 0.130 |
Why?
|
| Datasets as Topic | 1 | 2017 | 100 | 0.130 |
Why?
|
| DNA | 3 | 2024 | 1419 | 0.130 |
Why?
|
| High-Throughput Screening Assays | 2 | 2018 | 116 | 0.130 |
Why?
|
| Osteoblasts | 1 | 2018 | 177 | 0.130 |
Why?
|
| Amino Acid Oxidoreductases | 1 | 2016 | 10 | 0.130 |
Why?
|
| Programmed Cell Death 1 Receptor | 1 | 2018 | 143 | 0.130 |
Why?
|
| Bone Morphogenetic Protein 2 | 2 | 2014 | 87 | 0.130 |
Why?
|
| Chromatin Assembly and Disassembly | 2 | 2018 | 121 | 0.130 |
Why?
|
| Spindle Apparatus | 2 | 2014 | 49 | 0.130 |
Why?
|
| Retroviridae | 1 | 2017 | 182 | 0.130 |
Why?
|
| Nuclear Receptor Coactivator 3 | 2 | 2016 | 258 | 0.120 |
Why?
|
| Hepatocyte Nuclear Factor 3-alpha | 1 | 2016 | 44 | 0.120 |
Why?
|
| Exosomes | 1 | 2017 | 62 | 0.120 |
Why?
|
| Statistics, Nonparametric | 3 | 2012 | 426 | 0.120 |
Why?
|
| Aromatase Inhibitors | 1 | 2017 | 77 | 0.120 |
Why?
|
| Antineoplastic Agents, Immunological | 1 | 2018 | 124 | 0.120 |
Why?
|
| Forkhead Box Protein M1 | 1 | 2016 | 8 | 0.120 |
Why?
|
| Monocytes | 2 | 2016 | 336 | 0.120 |
Why?
|
| Polycomb Repressive Complex 2 | 2 | 2014 | 33 | 0.120 |
Why?
|
| Lymphocytes | 1 | 2018 | 348 | 0.120 |
Why?
|
| Coculture Techniques | 5 | 2017 | 232 | 0.120 |
Why?
|
| Focal Adhesion Protein-Tyrosine Kinases | 1 | 2016 | 25 | 0.120 |
Why?
|
| Carcinoma, Neuroendocrine | 1 | 2016 | 41 | 0.120 |
Why?
|
| Guanine Nucleotide Exchange Factors | 1 | 2016 | 102 | 0.120 |
Why?
|
| Pyrazoles | 3 | 2017 | 357 | 0.120 |
Why?
|
| Bone Morphogenetic Protein Receptors, Type I | 1 | 2015 | 32 | 0.120 |
Why?
|
| Integrin beta1 | 1 | 2016 | 53 | 0.120 |
Why?
|
| RNA Splicing Factors | 1 | 2016 | 51 | 0.120 |
Why?
|
| Receptors, Cell Surface | 1 | 2018 | 420 | 0.120 |
Why?
|
| Primary Myelofibrosis | 1 | 2016 | 53 | 0.120 |
Why?
|
| Adoptive Transfer | 2 | 2014 | 235 | 0.120 |
Why?
|
| Mixed Function Oxygenases | 1 | 2016 | 36 | 0.120 |
Why?
|
| Receptor, IGF Type 1 | 3 | 2011 | 94 | 0.120 |
Why?
|
| Duodenal Neoplasms | 1 | 2016 | 26 | 0.120 |
Why?
|
| Proto-Oncogene Proteins c-met | 1 | 2015 | 27 | 0.120 |
Why?
|
| Mice, 129 Strain | 5 | 2015 | 98 | 0.120 |
Why?
|
| Glioblastoma | 1 | 2020 | 378 | 0.120 |
Why?
|
| Retinoblastoma Protein | 2 | 2013 | 78 | 0.120 |
Why?
|
| Electron Transport Chain Complex Proteins | 1 | 2015 | 21 | 0.120 |
Why?
|
| Neutrophils | 1 | 2018 | 358 | 0.120 |
Why?
|
| Precancerous Conditions | 1 | 2018 | 280 | 0.120 |
Why?
|
| E2F1 Transcription Factor | 1 | 2016 | 49 | 0.120 |
Why?
|
| Tongue Neoplasms | 1 | 2015 | 30 | 0.120 |
Why?
|
| Proto-Oncogene Proteins c-ets | 1 | 2016 | 58 | 0.120 |
Why?
|
| Centrioles | 1 | 2015 | 5 | 0.120 |
Why?
|
| Inhibitor of Apoptosis Proteins | 2 | 2013 | 41 | 0.120 |
Why?
|
| Neuroglia | 1 | 2017 | 223 | 0.110 |
Why?
|
| GATA3 Transcription Factor | 2 | 2012 | 44 | 0.110 |
Why?
|
| Dioxygenases | 1 | 2016 | 70 | 0.110 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 1 | 2015 | 79 | 0.110 |
Why?
|
| Myeloid Cell Leukemia Sequence 1 Protein | 1 | 2015 | 20 | 0.110 |
Why?
|
| Molecular Sequence Data | 7 | 2016 | 3507 | 0.110 |
Why?
|
| Melanoma | 3 | 2013 | 918 | 0.110 |
Why?
|
| Oxidative Stress | 3 | 2015 | 798 | 0.110 |
Why?
|
| Fallopian Tubes | 2 | 2014 | 67 | 0.110 |
Why?
|
| Carcinoma, Ductal, Breast | 2 | 2013 | 87 | 0.110 |
Why?
|
| Mitochondria, Heart | 1 | 2015 | 60 | 0.110 |
Why?
|
| T-Lymphocytes | 2 | 2014 | 1711 | 0.110 |
Why?
|
| Saliva | 1 | 2015 | 125 | 0.110 |
Why?
|
| Biopsy | 3 | 2021 | 1237 | 0.110 |
Why?
|
| Transcription Factor RelA | 1 | 2015 | 53 | 0.110 |
Why?
|
| Oncogene Proteins, Fusion | 1 | 2017 | 244 | 0.110 |
Why?
|
| Ubiquitin-Conjugating Enzymes | 1 | 2015 | 37 | 0.110 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2015 | 88 | 0.110 |
Why?
|
| Immunotherapy | 1 | 2020 | 753 | 0.110 |
Why?
|
| Inhibitor of Differentiation Proteins | 2 | 2011 | 11 | 0.110 |
Why?
|
| Pyridones | 2 | 2013 | 147 | 0.110 |
Why?
|
| 3' Untranslated Regions | 2 | 2012 | 155 | 0.110 |
Why?
|
| Imidazoles | 2 | 2015 | 219 | 0.110 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 1 | 2014 | 57 | 0.110 |
Why?
|
| Conserved Sequence | 2 | 2012 | 281 | 0.110 |
Why?
|
| Dwarfism | 1 | 2015 | 105 | 0.110 |
Why?
|
| Energy Metabolism | 2 | 2017 | 799 | 0.110 |
Why?
|
| Aged, 80 and over | 8 | 2020 | 6779 | 0.110 |
Why?
|
| Ribonucleoside Diphosphate Reductase | 1 | 2014 | 12 | 0.110 |
Why?
|
| MCF-7 Cells | 4 | 2016 | 207 | 0.110 |
Why?
|
| Dioxolanes | 1 | 2014 | 10 | 0.110 |
Why?
|
| GTP Phosphohydrolases | 1 | 2015 | 158 | 0.110 |
Why?
|
| Cyclic AMP-Dependent Protein Kinase Catalytic Subunits | 1 | 2014 | 3 | 0.110 |
Why?
|
| Ubiquitin-Protein Ligases | 2 | 2014 | 361 | 0.100 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 3 | 2024 | 150 | 0.100 |
Why?
|
| MAP Kinase Kinase Kinase 3 | 1 | 2014 | 9 | 0.100 |
Why?
|
| CCAAT-Enhancer-Binding Protein-beta | 2 | 2013 | 37 | 0.100 |
Why?
|
| beta Karyopherins | 1 | 2014 | 16 | 0.100 |
Why?
|
| Drug Repositioning | 1 | 2014 | 31 | 0.100 |
Why?
|
| Interleukin-7 | 1 | 2014 | 46 | 0.100 |
Why?
|
| Guidelines as Topic | 1 | 2015 | 200 | 0.100 |
Why?
|
| Urogenital Abnormalities | 1 | 2016 | 159 | 0.100 |
Why?
|
| Virus Integration | 1 | 2014 | 37 | 0.100 |
Why?
|
| MEF2 Transcription Factors | 1 | 2014 | 35 | 0.100 |
Why?
|
| Chondroitin Sulfate Proteoglycans | 1 | 2013 | 31 | 0.100 |
Why?
|
| DNA, Complementary | 3 | 2010 | 431 | 0.100 |
Why?
|
| Adult Stem Cells | 1 | 2014 | 51 | 0.100 |
Why?
|
| Phosphofructokinase-2 | 1 | 2013 | 22 | 0.100 |
Why?
|
| Aspergillus niger | 1 | 2013 | 16 | 0.100 |
Why?
|
| ROC Curve | 3 | 2026 | 606 | 0.100 |
Why?
|
| GRB10 Adaptor Protein | 1 | 2013 | 6 | 0.100 |
Why?
|
| Activin Receptors, Type I | 1 | 2013 | 33 | 0.100 |
Why?
|
| Mammary Glands, Human | 2 | 2013 | 79 | 0.100 |
Why?
|
| Neurilemmoma | 1 | 2014 | 41 | 0.100 |
Why?
|
| Autoantigens | 1 | 2014 | 99 | 0.100 |
Why?
|
| Acetyl-CoA Carboxylase | 1 | 2013 | 17 | 0.100 |
Why?
|
| Chordoma | 1 | 2013 | 18 | 0.100 |
Why?
|
| Pentose Phosphate Pathway | 1 | 2013 | 44 | 0.100 |
Why?
|
| Spinal Cord Injuries | 1 | 2016 | 273 | 0.100 |
Why?
|
| Interleukin-15 | 1 | 2014 | 104 | 0.100 |
Why?
|
| Microarray Analysis | 4 | 2015 | 223 | 0.100 |
Why?
|
| Hyaluronan Receptors | 2 | 2013 | 64 | 0.100 |
Why?
|
| In Vitro Techniques | 3 | 2021 | 809 | 0.100 |
Why?
|
| Quantitative Trait Loci | 1 | 2015 | 304 | 0.100 |
Why?
|
| Citric Acid Cycle | 1 | 2013 | 43 | 0.100 |
Why?
|
| Synapses | 1 | 2017 | 448 | 0.100 |
Why?
|
| Respiratory Hypersensitivity | 1 | 2013 | 53 | 0.100 |
Why?
|
| Autocrine Communication | 1 | 2013 | 29 | 0.100 |
Why?
|
| Integrases | 3 | 2018 | 157 | 0.100 |
Why?
|
| Myotonic Dystrophy | 1 | 2014 | 74 | 0.100 |
Why?
|
| Endoribonucleases | 2 | 2010 | 88 | 0.100 |
Why?
|
| Skull Base Neoplasms | 1 | 2013 | 40 | 0.100 |
Why?
|
| Chemokine CXCL12 | 1 | 2013 | 34 | 0.100 |
Why?
|
| Sarcoma | 1 | 2015 | 216 | 0.100 |
Why?
|
| Treatment Outcome | 7 | 2020 | 12856 | 0.100 |
Why?
|
| Antigens, CD19 | 1 | 2014 | 188 | 0.100 |
Why?
|
| MAP Kinase Kinase Kinase 1 | 1 | 2012 | 15 | 0.100 |
Why?
|
| Genes, p16 | 1 | 2012 | 11 | 0.100 |
Why?
|
| Genes, erbB-2 | 1 | 2012 | 32 | 0.090 |
Why?
|
| Retinoblastoma-Binding Protein 7 | 1 | 2012 | 6 | 0.090 |
Why?
|
| Fibrinogen | 1 | 2013 | 166 | 0.090 |
Why?
|
| Immunologic Memory | 1 | 2014 | 194 | 0.090 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2013 | 137 | 0.090 |
Why?
|
| Tissue Distribution | 2 | 2010 | 364 | 0.090 |
Why?
|
| Peptide Hydrolases | 1 | 2013 | 130 | 0.090 |
Why?
|
| Primary Cell Culture | 3 | 2020 | 106 | 0.090 |
Why?
|
| Receptors, CXCR4 | 1 | 2013 | 69 | 0.090 |
Why?
|
| Mucin-4 | 1 | 2012 | 12 | 0.090 |
Why?
|
| M Phase Cell Cycle Checkpoints | 1 | 2012 | 4 | 0.090 |
Why?
|
| Genes, BRCA1 | 1 | 2012 | 59 | 0.090 |
Why?
|
| Leukemia, Myeloid, Chronic-Phase | 1 | 2012 | 11 | 0.090 |
Why?
|
| Cyclohexanecarboxylic Acids | 1 | 2012 | 18 | 0.090 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2015 | 376 | 0.090 |
Why?
|
| Chick Embryo | 2 | 2026 | 123 | 0.090 |
Why?
|
| Calcium-Binding Proteins | 2 | 2015 | 325 | 0.090 |
Why?
|
| Naphthoquinones | 1 | 2012 | 9 | 0.090 |
Why?
|
| Casein Kinase I | 1 | 2012 | 12 | 0.090 |
Why?
|
| Mitosis | 2 | 2011 | 194 | 0.090 |
Why?
|
| Immunoenzyme Techniques | 4 | 2013 | 236 | 0.090 |
Why?
|
| Reproducibility of Results | 5 | 2018 | 2920 | 0.090 |
Why?
|
| Fertility | 1 | 2014 | 256 | 0.090 |
Why?
|
| Ubiquitin-Activating Enzymes | 1 | 2011 | 22 | 0.090 |
Why?
|
| Metabolome | 4 | 2020 | 325 | 0.090 |
Why?
|
| Immunoblotting | 4 | 2015 | 293 | 0.090 |
Why?
|
| MAP Kinase Kinase 4 | 1 | 2011 | 34 | 0.090 |
Why?
|
| Genes, myc | 1 | 2011 | 95 | 0.090 |
Why?
|
| Thiazoles | 1 | 2012 | 111 | 0.090 |
Why?
|
| Proteolysis | 3 | 2018 | 197 | 0.090 |
Why?
|
| Finches | 1 | 2011 | 6 | 0.090 |
Why?
|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2012 | 102 | 0.090 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 4 | 1 | 2011 | 13 | 0.090 |
Why?
|
| Vocalization, Animal | 1 | 2011 | 19 | 0.090 |
Why?
|
| Keratin-6 | 1 | 2011 | 14 | 0.090 |
Why?
|
| Serum Response Factor | 1 | 2011 | 30 | 0.090 |
Why?
|
| Brain | 2 | 2021 | 3193 | 0.090 |
Why?
|
| RNA Splicing | 1 | 2012 | 237 | 0.090 |
Why?
|
| Purine-Nucleoside Phosphorylase | 1 | 2011 | 10 | 0.090 |
Why?
|
| Prosencephalon | 1 | 2011 | 41 | 0.090 |
Why?
|
| Chromatin Immunoprecipitation | 4 | 2014 | 228 | 0.090 |
Why?
|
| Trans-Activators | 2 | 2015 | 705 | 0.090 |
Why?
|
| PPAR gamma | 1 | 2011 | 87 | 0.090 |
Why?
|
| Auditory Cortex | 1 | 2011 | 28 | 0.080 |
Why?
|
| Neovascularization, Pathologic | 2 | 2021 | 229 | 0.080 |
Why?
|
| Lymphoma | 1 | 2014 | 328 | 0.080 |
Why?
|
| Triazines | 1 | 2010 | 34 | 0.080 |
Why?
|
| Eukaryotic Initiation Factor-3 | 1 | 2010 | 8 | 0.080 |
Why?
|
| Protein Biosynthesis | 2 | 2010 | 575 | 0.080 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2011 | 138 | 0.080 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-1 | 1 | 2010 | 43 | 0.080 |
Why?
|
| Cellular Senescence | 4 | 2015 | 217 | 0.080 |
Why?
|
| Boston | 1 | 2010 | 118 | 0.080 |
Why?
|
| Cell Nucleus | 1 | 2013 | 569 | 0.080 |
Why?
|
| Claudins | 1 | 2010 | 29 | 0.080 |
Why?
|
| Cell Dedifferentiation | 1 | 2010 | 21 | 0.080 |
Why?
|
| Diagnosis, Differential | 3 | 2025 | 1889 | 0.080 |
Why?
|
| Fluorescent Antibody Technique | 3 | 2020 | 413 | 0.080 |
Why?
|
| Enhancer of Zeste Homolog 2 Protein | 3 | 2019 | 70 | 0.080 |
Why?
|
| Prostate-Specific Antigen | 3 | 2016 | 227 | 0.080 |
Why?
|
| Interleukin-13 | 1 | 2010 | 98 | 0.080 |
Why?
|
| Age Factors | 3 | 2020 | 2835 | 0.080 |
Why?
|
| Myocytes, Cardiac | 1 | 2015 | 674 | 0.080 |
Why?
|
| Neoplasms, Plasma Cell | 1 | 2009 | 5 | 0.080 |
Why?
|
| Reference Values | 1 | 2011 | 678 | 0.080 |
Why?
|
| Antigens, Differentiation | 1 | 2010 | 65 | 0.080 |
Why?
|
| Lymphoma, Large-Cell, Immunoblastic | 1 | 2009 | 5 | 0.080 |
Why?
|
| Binding Sites | 4 | 2016 | 1150 | 0.080 |
Why?
|
| Nuclear Matrix-Associated Proteins | 1 | 2009 | 18 | 0.080 |
Why?
|
| Soft Tissue Neoplasms | 1 | 2011 | 127 | 0.080 |
Why?
|
| Myeloproliferative Disorders | 1 | 2011 | 93 | 0.080 |
Why?
|
| Matrix Attachment Region Binding Proteins | 1 | 2009 | 18 | 0.080 |
Why?
|
| AC133 Antigen | 3 | 2016 | 36 | 0.080 |
Why?
|
| Bone Marrow Cells | 1 | 2011 | 243 | 0.080 |
Why?
|
| Claudin-1 | 1 | 2009 | 19 | 0.080 |
Why?
|
| Extracellular Space | 1 | 2009 | 80 | 0.080 |
Why?
|
| Genetic Techniques | 1 | 2010 | 96 | 0.080 |
Why?
|
| CD24 Antigen | 1 | 2009 | 32 | 0.080 |
Why?
|
| Tumor Burden | 3 | 2017 | 240 | 0.080 |
Why?
|
| Cornea | 1 | 2014 | 561 | 0.080 |
Why?
|
| Evolution, Molecular | 1 | 2012 | 656 | 0.070 |
Why?
|
| Pregnancy Complications | 1 | 2014 | 537 | 0.070 |
Why?
|
| Congresses as Topic | 1 | 2010 | 185 | 0.070 |
Why?
|
| Mice, Mutant Strains | 3 | 2017 | 358 | 0.070 |
Why?
|
| Time Factors | 4 | 2017 | 6187 | 0.070 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 3 | 2020 | 783 | 0.070 |
Why?
|
| Focal Adhesions | 2 | 2021 | 14 | 0.070 |
Why?
|
| Young Adult | 7 | 2020 | 9992 | 0.070 |
Why?
|
| Chromatography, Liquid | 3 | 2020 | 236 | 0.070 |
Why?
|
| Genes | 2 | 2011 | 310 | 0.070 |
Why?
|
| Amino Acids | 1 | 2011 | 562 | 0.070 |
Why?
|
| Prospective Studies | 3 | 2020 | 6421 | 0.070 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2014 | 575 | 0.070 |
Why?
|
| Ovariectomy | 1 | 2008 | 157 | 0.070 |
Why?
|
| Biomarkers | 5 | 2018 | 3395 | 0.070 |
Why?
|
| Histones | 2 | 2026 | 546 | 0.070 |
Why?
|
| Comparative Genomic Hybridization | 1 | 2009 | 569 | 0.070 |
Why?
|
| Reactive Oxygen Species | 3 | 2016 | 510 | 0.070 |
Why?
|
| Tandem Mass Spectrometry | 3 | 2020 | 288 | 0.070 |
Why?
|
| rhoA GTP-Binding Protein | 2 | 2018 | 44 | 0.070 |
Why?
|
| Receptors, Adrenergic, beta-2 | 1 | 2007 | 57 | 0.070 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 1 | 2009 | 153 | 0.070 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 2 | 2018 | 144 | 0.070 |
Why?
|
| Sex Factors | 3 | 2020 | 1334 | 0.060 |
Why?
|
| Embryonic Stem Cells | 1 | 2008 | 157 | 0.060 |
Why?
|
| HCT116 Cells | 2 | 2019 | 61 | 0.060 |
Why?
|
| Radiation Tolerance | 2 | 2020 | 62 | 0.060 |
Why?
|
| Flow Cytometry | 3 | 2017 | 767 | 0.060 |
Why?
|
| Cell Membrane | 1 | 2009 | 451 | 0.060 |
Why?
|
| Sequence Alignment | 2 | 2011 | 585 | 0.060 |
Why?
|
| Oxidation-Reduction | 2 | 2019 | 434 | 0.060 |
Why?
|
| Aldehyde Dehydrogenase | 2 | 2017 | 41 | 0.060 |
Why?
|
| Mutagenesis, Site-Directed | 2 | 2017 | 302 | 0.060 |
Why?
|
| Diseases in Twins | 1 | 2006 | 88 | 0.060 |
Why?
|
| Amino Acid Sequence | 4 | 2014 | 2409 | 0.060 |
Why?
|
| Twins, Monozygotic | 1 | 2006 | 124 | 0.060 |
Why?
|
| Ligands | 3 | 2013 | 487 | 0.060 |
Why?
|
| MAP Kinase Kinase Kinases | 1 | 2006 | 56 | 0.060 |
Why?
|
| Biopsy, Needle | 2 | 2017 | 207 | 0.060 |
Why?
|
| Receptor, ErbB-3 | 2 | 2016 | 24 | 0.060 |
Why?
|
| NF-kappa B | 2 | 2020 | 442 | 0.060 |
Why?
|
| Paracrine Communication | 1 | 2025 | 67 | 0.060 |
Why?
|
| Co-Repressor Proteins | 2 | 2019 | 38 | 0.060 |
Why?
|
| Mitotic Index | 2 | 2017 | 17 | 0.060 |
Why?
|
| Microscopy, Fluorescence | 2 | 2020 | 304 | 0.060 |
Why?
|
| Active Transport, Cell Nucleus | 2 | 2017 | 120 | 0.060 |
Why?
|
| Dasatinib | 1 | 2025 | 53 | 0.050 |
Why?
|
| Blood Proteins | 1 | 2005 | 139 | 0.050 |
Why?
|
| Spheroids, Cellular | 2 | 2015 | 60 | 0.050 |
Why?
|
| Triazoles | 2 | 2017 | 138 | 0.050 |
Why?
|
| Electron Transport Complex I | 1 | 2024 | 31 | 0.050 |
Why?
|
| DNA Breaks, Double-Stranded | 1 | 2025 | 142 | 0.050 |
Why?
|
| Hexokinase | 1 | 2024 | 24 | 0.050 |
Why?
|
| Neoplasms, Hormone-Dependent | 2 | 2014 | 88 | 0.050 |
Why?
|
| Receptors, Eph Family | 1 | 2024 | 21 | 0.050 |
Why?
|
| Puberty | 1 | 2004 | 93 | 0.050 |
Why?
|
| Receptor, EphA2 | 1 | 2024 | 27 | 0.050 |
Why?
|
| Calcium-Transporting ATPases | 1 | 2024 | 37 | 0.050 |
Why?
|
| Cell Cycle Checkpoints | 2 | 2015 | 61 | 0.050 |
Why?
|
| Receptors, Antigen | 2 | 2014 | 33 | 0.050 |
Why?
|
| Manganese | 1 | 2024 | 57 | 0.050 |
Why?
|
| rap GTP-Binding Proteins | 1 | 2023 | 3 | 0.050 |
Why?
|
| Genomic Imprinting | 1 | 2024 | 123 | 0.050 |
Why?
|
| Complement C7 | 1 | 2023 | 2 | 0.050 |
Why?
|
| Species Specificity | 2 | 2015 | 486 | 0.050 |
Why?
|
| Alleles | 3 | 2017 | 1685 | 0.050 |
Why?
|
| B-Lymphocytes | 1 | 2006 | 509 | 0.050 |
Why?
|
| Chromosomes, Human | 2 | 2014 | 120 | 0.050 |
Why?
|
| Recombinational DNA Repair | 1 | 2023 | 17 | 0.050 |
Why?
|
| Rats | 3 | 2015 | 3400 | 0.050 |
Why?
|
| Hypoxia | 1 | 2005 | 247 | 0.050 |
Why?
|
| Proto-Oncogene Proteins B-raf | 2 | 2017 | 219 | 0.050 |
Why?
|
| Age of Onset | 1 | 2025 | 598 | 0.050 |
Why?
|
| Azepines | 2 | 2014 | 62 | 0.050 |
Why?
|
| Database Management Systems | 1 | 2003 | 26 | 0.050 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2006 | 283 | 0.050 |
Why?
|
| Sumoylation | 2 | 2014 | 48 | 0.050 |
Why?
|
| Metformin | 1 | 2025 | 169 | 0.050 |
Why?
|
| Doxycycline | 2 | 2014 | 111 | 0.050 |
Why?
|
| Small Molecule Libraries | 1 | 2024 | 132 | 0.050 |
Why?
|
| Cell-Matrix Junctions | 1 | 2022 | 9 | 0.050 |
Why?
|
| Gene Expression Regulation, Fungal | 1 | 2003 | 56 | 0.050 |
Why?
|
| Hedgehog Proteins | 2 | 2017 | 200 | 0.050 |
Why?
|
| Host-Pathogen Interactions | 1 | 2025 | 253 | 0.050 |
Why?
|
| Tumor Escape | 1 | 2003 | 62 | 0.050 |
Why?
|
| Peptides | 3 | 2013 | 708 | 0.050 |
Why?
|
| Aurora Kinases | 2 | 2012 | 27 | 0.050 |
Why?
|
| Heart Failure | 1 | 2015 | 2313 | 0.050 |
Why?
|
| Integrins | 1 | 2022 | 90 | 0.050 |
Why?
|
| Fungal Proteins | 1 | 2003 | 135 | 0.050 |
Why?
|
| Drug Synergism | 2 | 2016 | 235 | 0.050 |
Why?
|
| Doxorubicin | 2 | 2014 | 289 | 0.050 |
Why?
|
| Regeneration | 1 | 2024 | 230 | 0.050 |
Why?
|
| In Situ Nick-End Labeling | 2 | 2012 | 119 | 0.050 |
Why?
|
| Adaptor Protein Complex sigma Subunits | 1 | 2021 | 2 | 0.050 |
Why?
|
| Multigene Family | 2 | 2015 | 291 | 0.040 |
Why?
|
| Asthma | 1 | 2010 | 905 | 0.040 |
Why?
|
| Genomic Instability | 2 | 2016 | 244 | 0.040 |
Why?
|
| Luciferases | 2 | 2012 | 126 | 0.040 |
Why?
|
| 1-Phosphatidylinositol 4-Kinase | 1 | 2021 | 8 | 0.040 |
Why?
|
| Folic Acid | 1 | 2024 | 269 | 0.040 |
Why?
|
| Activin Receptors, Type II | 1 | 2021 | 30 | 0.040 |
Why?
|
| Alpha-Globulins | 1 | 2021 | 8 | 0.040 |
Why?
|
| Smad5 Protein | 1 | 2021 | 20 | 0.040 |
Why?
|
| Interleukin-2 | 1 | 2022 | 237 | 0.040 |
Why?
|
| Discoidin Domain Receptor 2 | 1 | 2021 | 5 | 0.040 |
Why?
|
| Smad1 Protein | 1 | 2021 | 23 | 0.040 |
Why?
|
| Taxoids | 2 | 2012 | 72 | 0.040 |
Why?
|
| Zinc Finger E-box Binding Homeobox 2 | 1 | 2021 | 6 | 0.040 |
Why?
|
| Organoids | 1 | 2024 | 304 | 0.040 |
Why?
|
| Endothelium | 1 | 2021 | 61 | 0.040 |
Why?
|
| Mouse Embryonic Stem Cells | 1 | 2021 | 32 | 0.040 |
Why?
|
| Acetylcholine | 1 | 2021 | 73 | 0.040 |
Why?
|
| Norepinephrine | 1 | 2021 | 152 | 0.040 |
Why?
|
| Genes, Reporter | 2 | 2012 | 342 | 0.040 |
Why?
|
| Lim Kinases | 1 | 2020 | 7 | 0.040 |
Why?
|
| Sphingomyelins | 1 | 2020 | 16 | 0.040 |
Why?
|
| In Situ Hybridization, Fluorescence | 2 | 2014 | 752 | 0.040 |
Why?
|
| Glycosphingolipids | 1 | 2020 | 12 | 0.040 |
Why?
|
| Cytoskeleton | 1 | 2021 | 165 | 0.040 |
Why?
|
| Polyribosomes | 2 | 2010 | 23 | 0.040 |
Why?
|
| Cell Separation | 2 | 2012 | 220 | 0.040 |
Why?
|
| Gene Drive Technology | 1 | 2020 | 6 | 0.040 |
Why?
|
| Biological Transport | 1 | 2021 | 332 | 0.040 |
Why?
|
| Genes, cdc | 1 | 2020 | 23 | 0.040 |
Why?
|
| Ubiquitin | 1 | 2021 | 132 | 0.040 |
Why?
|
| Longitudinal Studies | 1 | 2025 | 1484 | 0.040 |
Why?
|
| Pyrrolidines | 1 | 2020 | 46 | 0.040 |
Why?
|
| Jagged-2 Protein | 2 | 2011 | 4 | 0.040 |
Why?
|
| Neurotransmitter Agents | 1 | 2021 | 140 | 0.040 |
Why?
|
| Decision Making | 1 | 2006 | 687 | 0.040 |
Why?
|
| Ceramides | 1 | 2020 | 47 | 0.040 |
Why?
|
| Matrix Metalloproteinases | 1 | 2020 | 62 | 0.040 |
Why?
|
| Nucleotidyltransferases | 1 | 2020 | 46 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2017 | 1617 | 0.040 |
Why?
|
| Chromosomal Instability | 1 | 2020 | 58 | 0.040 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2003 | 400 | 0.040 |
Why?
|
| Gene Knockout Techniques | 1 | 2020 | 135 | 0.040 |
Why?
|
| Protein Transport | 1 | 2021 | 364 | 0.040 |
Why?
|
| CRISPR-Cas Systems | 1 | 2023 | 317 | 0.040 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 2021 | 179 | 0.040 |
Why?
|
| Serotonin | 1 | 2021 | 211 | 0.040 |
Why?
|
| Glutamic Acid | 1 | 2021 | 210 | 0.040 |
Why?
|
| Antigens, CD | 2 | 2013 | 410 | 0.040 |
Why?
|
| Analysis of Variance | 2 | 2013 | 938 | 0.040 |
Why?
|
| Nervous System | 1 | 2020 | 120 | 0.040 |
Why?
|
| Probability | 1 | 2020 | 306 | 0.040 |
Why?
|
| Glycoproteins | 2 | 2013 | 346 | 0.040 |
Why?
|
| Genotype | 2 | 2016 | 2605 | 0.040 |
Why?
|
| Myeloid-Lymphoid Leukemia Protein | 1 | 2020 | 80 | 0.040 |
Why?
|
| Glypicans | 1 | 2020 | 39 | 0.040 |
Why?
|
| Myxococcus xanthus | 1 | 1999 | 2 | 0.040 |
Why?
|
| Lysogeny | 1 | 1999 | 11 | 0.040 |
Why?
|
| Actins | 1 | 2021 | 315 | 0.040 |
Why?
|
| X-Ray Microtomography | 1 | 2020 | 100 | 0.040 |
Why?
|
| MAP Kinase Kinase 7 | 1 | 2019 | 12 | 0.040 |
Why?
|
| rab GTP-Binding Proteins | 1 | 2019 | 51 | 0.040 |
Why?
|
| Acetyltransferases | 1 | 2019 | 75 | 0.040 |
Why?
|
| Aerobiosis | 1 | 2019 | 13 | 0.040 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 2022 | 510 | 0.040 |
Why?
|
| Receptor Cross-Talk | 1 | 2019 | 36 | 0.040 |
Why?
|
| DNA Primers | 2 | 2011 | 606 | 0.040 |
Why?
|
| Histocytochemistry | 1 | 2019 | 83 | 0.040 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2022 | 463 | 0.040 |
Why?
|
| Graft vs Host Disease | 1 | 2024 | 682 | 0.040 |
Why?
|
| Skin Neoplasms | 1 | 2006 | 899 | 0.040 |
Why?
|
| Stem Cell Niche | 1 | 2019 | 56 | 0.040 |
Why?
|
| RNA-Binding Proteins | 2 | 2014 | 541 | 0.040 |
Why?
|
| Cysteine Proteinase Inhibitors | 1 | 2018 | 34 | 0.040 |
Why?
|
| GTP-Binding Protein alpha Subunits, G12-G13 | 1 | 2018 | 2 | 0.040 |
Why?
|
| Neuroepithelial Cells | 1 | 2018 | 8 | 0.030 |
Why?
|
| Protein Tyrosine Phosphatases, Non-Receptor | 1 | 2018 | 19 | 0.030 |
Why?
|
| Exocytosis | 1 | 2018 | 66 | 0.030 |
Why?
|
| Lentivirus | 1 | 2018 | 81 | 0.030 |
Why?
|
| Bacteriophages | 1 | 1999 | 97 | 0.030 |
Why?
|
| Lipid Metabolism | 1 | 2021 | 373 | 0.030 |
Why?
|
| Recombination, Genetic | 1 | 1999 | 422 | 0.030 |
Why?
|
| Chemokines | 2 | 2008 | 124 | 0.030 |
Why?
|
| Acetylcholine Release Inhibitors | 1 | 2017 | 17 | 0.030 |
Why?
|
| Web Browser | 1 | 2017 | 7 | 0.030 |
Why?
|
| Endothelial Cells | 1 | 2021 | 520 | 0.030 |
Why?
|
| Role | 1 | 2017 | 26 | 0.030 |
Why?
|
| Axons | 1 | 2020 | 388 | 0.030 |
Why?
|
| Receptor, trkC | 1 | 2017 | 13 | 0.030 |
Why?
|
| Leucine | 1 | 2018 | 259 | 0.030 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2019 | 233 | 0.030 |
Why?
|
| Th17 Cells | 1 | 2018 | 96 | 0.030 |
Why?
|
| Immunophenotyping | 1 | 2018 | 330 | 0.030 |
Why?
|
| Receptors, OSM-LIF | 1 | 2017 | 6 | 0.030 |
Why?
|
| Prostatectomy | 1 | 2018 | 300 | 0.030 |
Why?
|
| Protein Isoforms | 1 | 2018 | 420 | 0.030 |
Why?
|
| Bone Morphogenetic Protein Receptors | 1 | 2017 | 12 | 0.030 |
Why?
|
| Oxidoreductases Acting on CH-NH Group Donors | 1 | 2017 | 25 | 0.030 |
Why?
|
| Fusion Proteins, bcr-abl | 1 | 2017 | 44 | 0.030 |
Why?
|
| Feasibility Studies | 1 | 2020 | 813 | 0.030 |
Why?
|
| Diet | 1 | 2024 | 1097 | 0.030 |
Why?
|
| Hydronephrosis | 1 | 2017 | 34 | 0.030 |
Why?
|
| Bone Morphogenetic Protein 4 | 1 | 2017 | 40 | 0.030 |
Why?
|
| Rho Guanine Nucleotide Exchange Factors | 1 | 2016 | 16 | 0.030 |
Why?
|
| Ubiquitination | 1 | 2017 | 169 | 0.030 |
Why?
|
| Lipids | 1 | 2020 | 562 | 0.030 |
Why?
|
| Androstadienes | 1 | 2017 | 50 | 0.030 |
Why?
|
| Interleukin-1alpha | 1 | 2016 | 11 | 0.030 |
Why?
|
| Serum Amyloid P-Component | 1 | 2016 | 14 | 0.030 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2017 | 91 | 0.030 |
Why?
|
| Biological Ontologies | 1 | 2016 | 7 | 0.030 |
Why?
|
| Neural Stem Cells | 1 | 2018 | 136 | 0.030 |
Why?
|
| Sterol Regulatory Element Binding Protein 1 | 1 | 2016 | 31 | 0.030 |
Why?
|
| Nephrons | 1 | 2016 | 17 | 0.030 |
Why?
|
| Leukocyte Common Antigens | 1 | 2016 | 84 | 0.030 |
Why?
|
| Neutrophil Infiltration | 1 | 2016 | 62 | 0.030 |
Why?
|
| Chemokine CXCL10 | 1 | 2016 | 52 | 0.030 |
Why?
|
| Risk Factors | 2 | 2026 | 10937 | 0.030 |
Why?
|
| User-Computer Interface | 1 | 2017 | 158 | 0.030 |
Why?
|
| Lysosomes | 1 | 2018 | 269 | 0.030 |
Why?
|
| Mechanistic Target of Rapamycin Complex 1 | 1 | 2017 | 178 | 0.030 |
Why?
|
| Chemokine CCL2 | 1 | 2016 | 112 | 0.030 |
Why?
|
| Ampulla of Vater | 1 | 2016 | 15 | 0.030 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2017 | 169 | 0.030 |
Why?
|
| Interleukin-1beta | 1 | 2016 | 157 | 0.030 |
Why?
|
| 5-Methylcytosine | 1 | 2016 | 29 | 0.030 |
Why?
|
| Spinal Cord | 1 | 2017 | 261 | 0.030 |
Why?
|
| CCN Intercellular Signaling Proteins | 1 | 2015 | 1 | 0.030 |
Why?
|
| Blastocyst | 1 | 2015 | 72 | 0.030 |
Why?
|
| Menstrual Cycle | 1 | 2016 | 32 | 0.030 |
Why?
|
| Cyclin-Dependent Kinases | 1 | 2016 | 82 | 0.030 |
Why?
|
| Cytosine | 1 | 2016 | 57 | 0.030 |
Why?
|
| Phorbols | 1 | 2015 | 5 | 0.030 |
Why?
|
| G1 Phase Cell Cycle Checkpoints | 1 | 2015 | 15 | 0.030 |
Why?
|
| Cloning, Molecular | 1 | 2017 | 782 | 0.030 |
Why?
|
| Protein Domains | 1 | 2016 | 253 | 0.030 |
Why?
|
| Laser Capture Microdissection | 1 | 2015 | 9 | 0.030 |
Why?
|
| Tetrahydronaphthalenes | 1 | 2015 | 29 | 0.030 |
Why?
|
| Bone and Bones | 1 | 2018 | 307 | 0.030 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2015 | 81 | 0.030 |
Why?
|
| Gene Transfer Techniques | 1 | 2017 | 343 | 0.030 |
Why?
|
| Models, Molecular | 2 | 2011 | 1058 | 0.030 |
Why?
|
| Tubulin | 1 | 2015 | 76 | 0.030 |
Why?
|
| Calcineurin | 1 | 2015 | 59 | 0.030 |
Why?
|
| Microsatellite Repeats | 1 | 2016 | 210 | 0.030 |
Why?
|
| Transcriptional Regulator ERG | 1 | 2015 | 39 | 0.030 |
Why?
|
| Valine | 1 | 2015 | 109 | 0.030 |
Why?
|
| Histological Techniques | 1 | 2015 | 19 | 0.030 |
Why?
|
| Tomography, Optical | 1 | 2015 | 7 | 0.030 |
Why?
|
| Preoperative Period | 1 | 2015 | 90 | 0.030 |
Why?
|
| Caco-2 Cells | 1 | 2015 | 86 | 0.030 |
Why?
|
| Enzyme Induction | 1 | 2015 | 92 | 0.030 |
Why?
|
| Bone Morphogenetic Protein 6 | 1 | 2014 | 8 | 0.030 |
Why?
|
| Pteridines | 1 | 2014 | 10 | 0.030 |
Why?
|
| Follow-Up Studies | 2 | 2017 | 5186 | 0.030 |
Why?
|
| Synteny | 1 | 2015 | 69 | 0.030 |
Why?
|
| Mitochondrial Dynamics | 1 | 2015 | 53 | 0.030 |
Why?
|
| Polymorphism, Genetic | 1 | 2018 | 776 | 0.030 |
Why?
|
| Kallikreins | 1 | 2014 | 26 | 0.030 |
Why?
|
| Cell Shape | 1 | 2015 | 67 | 0.030 |
Why?
|
| Tripartite Motif-Containing Protein 28 | 1 | 2014 | 16 | 0.030 |
Why?
|
| Sequence Deletion | 1 | 2017 | 521 | 0.030 |
Why?
|
| Transduction, Genetic | 1 | 2015 | 279 | 0.030 |
Why?
|
| Anoikis | 1 | 2014 | 8 | 0.030 |
Why?
|
| Genetic Vectors | 1 | 2018 | 902 | 0.030 |
Why?
|
| Tripartite Motif Proteins | 1 | 2014 | 24 | 0.030 |
Why?
|
| Oxygen Consumption | 1 | 2015 | 298 | 0.030 |
Why?
|
| Chickens | 1 | 2014 | 269 | 0.030 |
Why?
|
| Fibrosis | 1 | 2016 | 419 | 0.030 |
Why?
|
| Chromosome Breakpoints | 1 | 2014 | 82 | 0.030 |
Why?
|
| Bone Marrow | 1 | 2016 | 319 | 0.030 |
Why?
|
| WNK Lysine-Deficient Protein Kinase 1 | 1 | 2014 | 14 | 0.030 |
Why?
|
| Gonanes | 1 | 2014 | 13 | 0.030 |
Why?
|
| Wnt4 Protein | 1 | 2014 | 23 | 0.030 |
Why?
|
| Neoadjuvant Therapy | 1 | 2017 | 394 | 0.030 |
Why?
|
| Zinc Fingers | 1 | 2014 | 117 | 0.030 |
Why?
|
| Piperidones | 1 | 2014 | 10 | 0.030 |
Why?
|
| Minor Histocompatibility Antigens | 1 | 2014 | 39 | 0.030 |
Why?
|
| Japan | 1 | 2014 | 166 | 0.030 |
Why?
|
| Surface Plasmon Resonance | 1 | 2014 | 54 | 0.030 |
Why?
|
| E-Selectin | 1 | 2014 | 38 | 0.030 |
Why?
|
| Postoperative Period | 1 | 2015 | 329 | 0.030 |
Why?
|
| Principal Component Analysis | 1 | 2014 | 153 | 0.030 |
Why?
|
| TNF-Related Apoptosis-Inducing Ligand | 1 | 2014 | 21 | 0.030 |
Why?
|
| Colony-Forming Units Assay | 1 | 2014 | 63 | 0.030 |
Why?
|
| Cytoskeletal Proteins | 1 | 2015 | 267 | 0.030 |
Why?
|
| Genome, Viral | 1 | 2014 | 159 | 0.030 |
Why?
|
| Hysterectomy | 1 | 2016 | 199 | 0.030 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 2015 | 198 | 0.030 |
Why?
|
| Aspergillus oryzae | 1 | 2013 | 8 | 0.030 |
Why?
|
| Activins | 1 | 2013 | 71 | 0.030 |
Why?
|
| Piperazines | 1 | 2015 | 270 | 0.030 |
Why?
|
| Hepatitis B virus | 1 | 2014 | 137 | 0.030 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 1 | 2014 | 72 | 0.030 |
Why?
|
| Area Under Curve | 1 | 2014 | 319 | 0.030 |
Why?
|
| Etoposide | 1 | 2014 | 109 | 0.030 |
Why?
|
| Loss of Heterozygosity | 1 | 2014 | 124 | 0.030 |
Why?
|
| rac GTP-Binding Proteins | 1 | 2013 | 24 | 0.030 |
Why?
|
| Human Umbilical Vein Endothelial Cells | 1 | 2014 | 95 | 0.030 |
Why?
|
| Choristoma | 1 | 2013 | 46 | 0.030 |
Why?
|
| Bone Marrow Transplantation | 1 | 2016 | 590 | 0.020 |
Why?
|
| Janus Kinases | 1 | 2013 | 34 | 0.020 |
Why?
|
| Fluorouracil | 1 | 2014 | 132 | 0.020 |
Why?
|
| Antibodies | 1 | 2014 | 320 | 0.020 |
Why?
|
| Hybrid Cells | 1 | 2013 | 77 | 0.020 |
Why?
|
| Macrophage Activation | 1 | 2013 | 65 | 0.020 |
Why?
|
| Calcium | 1 | 2018 | 1027 | 0.020 |
Why?
|
| Liposarcoma, Myxoid | 1 | 2013 | 3 | 0.020 |
Why?
|
| Bronchoalveolar Lavage Fluid | 1 | 2013 | 150 | 0.020 |
Why?
|
| Epidemiologic Factors | 1 | 2013 | 9 | 0.020 |
Why?
|
| Integrin alpha6 | 1 | 2013 | 5 | 0.020 |
Why?
|
| Cell Hypoxia | 1 | 2013 | 83 | 0.020 |
Why?
|
| snRNP Core Proteins | 1 | 2012 | 8 | 0.020 |
Why?
|
| Glucuronidase | 1 | 2013 | 32 | 0.020 |
Why?
|
| Adenomatous Polyposis Coli Protein | 1 | 2013 | 25 | 0.020 |
Why?
|
| Microscopy, Electron, Scanning Transmission | 1 | 2012 | 5 | 0.020 |
Why?
|
| MutL Protein Homolog 1 | 1 | 2013 | 52 | 0.020 |
Why?
|
| Models, Animal | 1 | 2015 | 455 | 0.020 |
Why?
|
| Microsatellite Instability | 1 | 2013 | 38 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 2016 | 1323 | 0.020 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2013 | 58 | 0.020 |
Why?
|
| Respiratory Mucosa | 1 | 2013 | 93 | 0.020 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 2013 | 272 | 0.020 |
Why?
|
| BRCA2 Protein | 1 | 2012 | 56 | 0.020 |
Why?
|
| Hepacivirus | 1 | 2014 | 273 | 0.020 |
Why?
|
| Th2 Cells | 1 | 2013 | 184 | 0.020 |
Why?
|
| Neovascularization, Physiologic | 1 | 2014 | 194 | 0.020 |
Why?
|
| Radiotherapy, Adjuvant | 1 | 2013 | 157 | 0.020 |
Why?
|
| Polycomb-Group Proteins | 1 | 2012 | 23 | 0.020 |
Why?
|
| Antigens, Surface | 1 | 2013 | 112 | 0.020 |
Why?
|
| BRCA1 Protein | 1 | 2012 | 82 | 0.020 |
Why?
|
| Genetic Association Studies | 1 | 2016 | 823 | 0.020 |
Why?
|
| Blast Crisis | 1 | 2012 | 17 | 0.020 |
Why?
|
| Mesothelioma | 1 | 2013 | 93 | 0.020 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2013 | 126 | 0.020 |
Why?
|
| Mice, Hairless | 1 | 2012 | 30 | 0.020 |
Why?
|
| Centrosome | 1 | 2012 | 28 | 0.020 |
Why?
|
| Adenosine Triphosphate | 1 | 2013 | 263 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2015 | 1113 | 0.020 |
Why?
|
| Skin | 1 | 2015 | 543 | 0.020 |
Why?
|
| Chromosome Mapping | 1 | 2015 | 1053 | 0.020 |
Why?
|
| Neurofibromatosis 1 | 1 | 2013 | 71 | 0.020 |
Why?
|
| Fallopian Tube Neoplasms | 1 | 2012 | 11 | 0.020 |
Why?
|
| Embryo, Mammalian | 1 | 2014 | 400 | 0.020 |
Why?
|
| Antigens, CD34 | 1 | 2012 | 97 | 0.020 |
Why?
|
| Cytoplasm | 1 | 2013 | 253 | 0.020 |
Why?
|
| Myometrium | 1 | 2012 | 47 | 0.020 |
Why?
|
| Collagen Type IV | 1 | 2011 | 20 | 0.020 |
Why?
|
| Models, Statistical | 1 | 2014 | 482 | 0.020 |
Why?
|
| Lymphocyte Activation | 1 | 2014 | 630 | 0.020 |
Why?
|
| Estrogen Antagonists | 1 | 2012 | 92 | 0.020 |
Why?
|
| Bromodeoxyuridine | 1 | 2011 | 55 | 0.020 |
Why?
|
| Deoxycytidine | 1 | 2012 | 81 | 0.020 |
Why?
|
| Cyclin D1 | 1 | 2012 | 108 | 0.020 |
Why?
|
| Schwann Cells | 1 | 2012 | 62 | 0.020 |
Why?
|
| Trastuzumab | 1 | 2012 | 136 | 0.020 |
Why?
|
| Oviducts | 1 | 2012 | 99 | 0.020 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2013 | 392 | 0.020 |
Why?
|
| Computer Simulation | 1 | 2015 | 676 | 0.020 |
Why?
|
| Enzyme Stability | 1 | 2011 | 58 | 0.020 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2014 | 694 | 0.020 |
Why?
|
| Fibronectins | 1 | 2011 | 100 | 0.020 |
Why?
|
| Avian Leukosis Virus | 1 | 2011 | 12 | 0.020 |
Why?
|
| Seizures | 1 | 2017 | 877 | 0.020 |
Why?
|
| Chromosome Deletion | 1 | 2014 | 653 | 0.020 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2014 | 641 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2015 | 1452 | 0.020 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2014 | 599 | 0.020 |
Why?
|
| Enzyme Inhibitors | 1 | 2014 | 568 | 0.020 |
Why?
|
| Acoustic Stimulation | 1 | 2011 | 92 | 0.020 |
Why?
|
| Smoking | 1 | 2016 | 923 | 0.020 |
Why?
|
| Cell Line, Transformed | 1 | 2011 | 160 | 0.020 |
Why?
|
| Methylation | 1 | 2011 | 197 | 0.020 |
Why?
|
| Gene Frequency | 1 | 2013 | 739 | 0.020 |
Why?
|
| F-Box-WD Repeat-Containing Protein 7 | 1 | 2010 | 20 | 0.020 |
Why?
|
| NIH 3T3 Cells | 1 | 2010 | 91 | 0.020 |
Why?
|
| Neoplasms, Glandular and Epithelial | 1 | 2011 | 44 | 0.020 |
Why?
|
| Receptor, Insulin | 1 | 2010 | 63 | 0.020 |
Why?
|
| Immunity, Innate | 1 | 2013 | 405 | 0.020 |
Why?
|
| F-Box Proteins | 1 | 2010 | 32 | 0.020 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2011 | 623 | 0.020 |
Why?
|
| Organ Specificity | 1 | 2011 | 397 | 0.020 |
Why?
|
| Aorta | 1 | 2014 | 520 | 0.020 |
Why?
|
| Drug Resistance | 1 | 2011 | 247 | 0.020 |
Why?
|
| Kidney | 1 | 2017 | 1283 | 0.020 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 2 | 1 | 2010 | 37 | 0.020 |
Why?
|
| Cell Compartmentation | 1 | 2010 | 38 | 0.020 |
Why?
|
| Smoothened Receptor | 1 | 2010 | 32 | 0.020 |
Why?
|
| Benzimidazoles | 1 | 2011 | 155 | 0.020 |
Why?
|
| Ribosomes | 1 | 2010 | 124 | 0.020 |
Why?
|
| Animals, Newborn | 1 | 2013 | 1018 | 0.020 |
Why?
|
| Biomedical Research | 1 | 2016 | 559 | 0.020 |
Why?
|
| Random Allocation | 1 | 2010 | 416 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2015 | 2106 | 0.020 |
Why?
|
| Everolimus | 1 | 2010 | 48 | 0.020 |
Why?
|
| Lymphoma, AIDS-Related | 1 | 2009 | 27 | 0.020 |
Why?
|
| Organogenesis | 1 | 2010 | 80 | 0.020 |
Why?
|
| Echocardiography | 1 | 2015 | 1125 | 0.020 |
Why?
|
| Genetic Loci | 1 | 2011 | 356 | 0.020 |
Why?
|
| Cell Death | 1 | 2010 | 233 | 0.020 |
Why?
|
| Receptors, Interleukin-1 | 1 | 2009 | 25 | 0.020 |
Why?
|
| Serrate-Jagged Proteins | 1 | 2009 | 35 | 0.020 |
Why?
|
| Proteasome Inhibitors | 1 | 2009 | 53 | 0.020 |
Why?
|
| Genetic Therapy | 1 | 2014 | 718 | 0.020 |
Why?
|
| Jagged-1 Protein | 1 | 2009 | 51 | 0.020 |
Why?
|
| Aging | 1 | 2016 | 1253 | 0.020 |
Why?
|
| Interleukin-1 | 1 | 2009 | 129 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2012 | 1377 | 0.020 |
Why?
|
| Retrospective Studies | 2 | 2020 | 17606 | 0.020 |
Why?
|
| Culture Media, Conditioned | 1 | 2008 | 84 | 0.020 |
Why?
|
| Neuroblastoma | 1 | 2013 | 544 | 0.020 |
Why?
|
| Blotting, Northern | 1 | 2008 | 236 | 0.020 |
Why?
|
| Adenocarcinoma, Bronchiolo-Alveolar | 1 | 2008 | 10 | 0.020 |
Why?
|
| False Positive Reactions | 1 | 2008 | 143 | 0.020 |
Why?
|
| Tretinoin | 1 | 2008 | 95 | 0.020 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2012 | 567 | 0.020 |
Why?
|
| Microspheres | 1 | 2007 | 67 | 0.020 |
Why?
|
| Logistic Models | 1 | 2012 | 1799 | 0.020 |
Why?
|
| Genome-Wide Association Study | 1 | 2015 | 1838 | 0.020 |
Why?
|
| 11-beta-Hydroxysteroid Dehydrogenase Type 2 | 1 | 2006 | 2 | 0.020 |
Why?
|
| Cysteine-Rich Protein 61 | 1 | 2006 | 6 | 0.020 |
Why?
|
| Metalloproteases | 1 | 2006 | 14 | 0.020 |
Why?
|
| Synovial Membrane | 1 | 2006 | 27 | 0.020 |
Why?
|
| DNA Fingerprinting | 1 | 2006 | 107 | 0.020 |
Why?
|
| Angiogenic Proteins | 1 | 2006 | 15 | 0.020 |
Why?
|
| Immediate-Early Proteins | 1 | 2006 | 57 | 0.010 |
Why?
|
| HIV-1 | 1 | 2009 | 480 | 0.010 |
Why?
|
| Chromatography | 1 | 2005 | 29 | 0.010 |
Why?
|
| Trypsin | 1 | 2005 | 68 | 0.010 |
Why?
|
| Lectins | 1 | 2005 | 50 | 0.010 |
Why?
|
| Protein Sorting Signals | 1 | 2005 | 44 | 0.010 |
Why?
|
| Databases, Protein | 1 | 2005 | 63 | 0.010 |
Why?
|
| Models, Genetic | 1 | 2008 | 748 | 0.010 |
Why?
|
| Statistics as Topic | 1 | 2005 | 239 | 0.010 |
Why?
|
| Osteoarthritis | 1 | 2006 | 104 | 0.010 |
Why?
|
| Blood Coagulation | 1 | 2005 | 134 | 0.010 |
Why?
|
| Cadaver | 1 | 2004 | 117 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2016 | 3816 | 0.010 |
Why?
|
| Phagocytosis | 1 | 2005 | 189 | 0.010 |
Why?
|
| Urinary Bladder | 1 | 2004 | 219 | 0.010 |
Why?
|
| Tissue Donors | 1 | 2004 | 502 | 0.010 |
Why?
|
| RNA, Transfer, Asp | 1 | 1999 | 2 | 0.010 |
Why?
|
| Proviruses | 1 | 1999 | 19 | 0.010 |
Why?
|
| Viral Structural Proteins | 1 | 1999 | 39 | 0.010 |
Why?
|
| Genes, Viral | 1 | 1999 | 155 | 0.010 |
Why?
|
| United States | 1 | 2014 | 11819 | 0.010 |
Why?
|
| Genes, Bacterial | 1 | 1999 | 216 | 0.010 |
Why?
|
| Genome, Bacterial | 1 | 1999 | 208 | 0.010 |
Why?
|
| Liver | 1 | 2005 | 1797 | 0.010 |
Why?
|